---
title: "Ironwood Pharma 2026 年第一季度財報預覽"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/285408430.md"
description: "Ironwood 醫藥（IRWD）將於 5 月 7 日公佈其第一季度財報，市場普遍預期每股收益（EPS）為 0.24 美元，收入預期為 9210 萬美元。歷史上，IRWD 在過去兩年中有 13% 的時間超出每股收益預期，50% 的時間超出收入預期"
datetime: "2026-05-06T16:03:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285408430.md)
  - [en](https://longbridge.com/en/news/285408430.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285408430.md)
---

# Ironwood Pharma 2026 年第一季度財報預覽

Ironwood Pharmaceuticals (IRWD) is scheduled to announce Q1 earnings results on Thursday, May 7th, before market open. The consensus EPS Estimate is $0.24 and the consensus Revenue Estimate is $92.1M. Over the last 2 years, IRWD has beaten EPS estimates 13% of the time and has beaten revenue estimates 50% of the time. Over the last 3 months, EPS es...

### 相關股票

- [IRWD.US](https://longbridge.com/zh-HK/quote/IRWD.US.md)

## 相關資訊與研究

- [Ironwood 醫藥｜8-K：2026 財年 Q1 營收 1.07 億美元超過預期](https://longbridge.com/zh-HK/news/285537526.md)
- [長江生命科技附屬順譜醫藥科技委任陳麗娟為營運總監](https://longbridge.com/zh-HK/news/286705435.md)
- [全球藥物韌性高峰會登場 經濟部佈局數位製造](https://longbridge.com/zh-HK/news/287002422.md)
- [禮邦醫藥港交所 IPO：去年行政開支增幅超 300% 淨虧損擴大](https://longbridge.com/zh-HK/news/287153722.md)
- [徵祥醫藥赴港 IPO：營收 35 萬，累計虧損約 2.9 億 未來盈利任重道遠](https://longbridge.com/zh-HK/news/286843416.md)